Pharmaceutical Executive
Brussels, Belgium-Tackling communicable diseases such as malaria and tuberculosis and making pregnancy and childbirth safer are priorities for the restructured Afghan health ministry, according to World Health Organization officials.
Brussels, Belgium-Tackling communicable diseases such as malaria and tuberculosis and making pregnancy and childbirth safer are priorities for the restructured Afghan health ministry, according to World Health Organization officials.
WHO, the United Nations Children's Fund, and non-governmental organizations have launched an appeal for nearly $130 million for immediate reconstruction of the war-torn country's health system, including vital medicines.
"Developing a functional healthcare system must be a top priority in the reconstruction of Afghanistan," says Dr. Mohammed Jama, WHO regional coordinator for the Afghanistan crisis. "As long as hundreds of thousands of Afghans continue to die from preventable diseases, a stable future for the country cannot be guaranteed."
A WHO mission to Afghanistan revealed a shortage of essential medicines that donations have only marginally improved in recent months. WHO is asking for $25 million to set up medical stores across the country.
Other priorities include the integrated management of childhood illnesses, the establishment of mental health services, and a safe blood transfusion service. "This package of basic services is designed to offer the basis of acceptable healthcare in Afghanistan," says Dr. Said Youssouf, WHO representative in Afghanistan.
The WHO appeal would amount to spending slightly more than $5 per person per year in Afghanistan. The organization estimates that $34 per person per year is needed for basic health services, but the present Afghani health infrastructure cannot handle such large amounts.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.